Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01061242|
Recruitment Status : Completed
First Posted : February 3, 2010
Last Update Posted : June 23, 2011
|Condition or disease||Intervention/treatment||Phase|
|Neurobehavioral Manifestations Sleep Deprivation Dyssomnias||Behavioral: Sleep promoting interventions||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||88 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Post-ICU Neurocognitive Performance and Sleep Quality Ratings Following Exposure to a Medical ICU Sleep Quality Improvement Project|
|Study Start Date :||January 2010|
|Actual Primary Completion Date :||July 2010|
|Actual Study Completion Date :||July 2010|
No Intervention: Baseline
Post-Intensive Care Unit (ICU) neurocognitive testing and sleep survey performed on patients exposed to ad-lib Medical ICU environment.
Experimental: Sleep Promotion Group
Post-ICU neurocognitive testing and sleep survey performed on patients exposed to interventions in the pre-existing MICU sleep quality improvement project.
Behavioral: Sleep promoting interventions
MICU staff will implement multi-faceted, staged sleep promoting interventions as part of a pre-existing sleep quality improvement project.
- Digit span test score [ Time Frame: within 96 hours of Intensive Care Unit (ICU) discharge ]
- Sleep in the ICU Questionnaire [ Time Frame: within 96 hours of ICU discharge ]
- Trail Making Test (Part A + B) times [ Time Frame: within 96 hours of ICU discharge ]
- Delirium status [ Time Frame: within 96 hours of ICU discharge ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01061242
|United States, Maryland|
|Johns Hopkins Hospital|
|Baltimore, Maryland, United States, 21205|